Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | PEBBLEBROOK HOTEL TR PEB | T. Rowe Price Associates, Inc. | 8,581,279 7.600% | 2,400,479![]() (+38.84%) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | NATERA INC NTRA | T. Rowe Price Associates, Inc. | 9,021,825 6.300% | -1,850,877![]() (-17.02%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | EXPRO GROUP HLDGS NV COM XPRO | T. Rowe Price Associates, Inc. | 14,162,759 12.500% | 2,044,308![]() (+16.87%) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | MEDIWOUND LTD MDWD | T. Rowe Price Associates, Inc. | 641,075 5.000% | -68,772![]() (-9.69%) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | INSTALLED BUILDING PRODUCTS IN IBP | T. Rowe Price Associates, Inc. | 1,161,708 4.300% | -389,455![]() (-25.11%) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | BLOCK,INC CLASS A XYZ | T. Rowe Price Associates, Inc. | 39,734,450 7.400% | -7,797,736![]() (-16.41%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | T. Rowe Price Associates, Inc. | 5,748,426 5.200% | 5,748,426![]() (New Position) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | MEDPACE HLDGS INC MEDP | T. Rowe Price Associates, Inc. | 2,069,679 7.200% | 2,069,679![]() (New Position) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | GUARDANT HEALTH INC GH | T. Rowe Price Associates, Inc. | 6,514,828 4.900% | -520,943![]() (-7.40%) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | TECHNIPFMC PLC COM FTI | T. Rowe Price Associates, Inc. | 25,718,037 6.500% | -5,576,541![]() (-17.82%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | INGERSOLL RAND INC IR | T. Rowe Price Associates, Inc. | 27,021,828 6.900% | 6,681,466![]() (+32.85%) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | ARGENX SE SPONSORED ADS ARGX | T. Rowe Price Associates, Inc. | 2,675,457 4.300% | -971,543![]() (-26.64%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | IQIYI INC SPONSORED ADR IQ | T. Rowe Price Associates, Inc. | 94,877,753 17.700% | 6,424,259![]() (+7.26%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | EQUITABLE HLDGS INC EQH | T. Rowe Price Associates, Inc. | 18,270,539 6.700% | 1,480,921![]() (+8.82%) | Filing History |
| 2026-08-14 10:38 am Sale | 2026-06-30 | 13G | VERRA MOBILITY CORP COM VRRM | T. Rowe Price Associates, Inc. | 241,697 0.200% | -9,370,743![]() (-97.49%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | TWIST BIOSCIENCE CORP COM TWST | T. Rowe Price Associates, Inc. | 3,634,470 5.800% | 3,634,470![]() (New Position) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | NURIX THERAPEUTICS INC NRIX | T. Rowe Price Associates, Inc. | 5,436,587 5.300% | 3,044,721![]() (+127.29%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | KYMERA THERAPEUTICS INC KYMR | T. Rowe Price Associates, Inc. | 7,112,345 8.600% | 2,014,641![]() (+39.52%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | ARRAY TECHNOLOGIES INC ARRY | T. Rowe Price Associates, Inc. | 8,642,626 5.600% | 7,510,328![]() (+663.28%) | Filing History |
| 2026-08-14 10:38 am Purchase | 2026-06-30 | 13G | CULLINAN THERAPEUTICS INC CGEM | T. Rowe Price Associates, Inc. | 3,825,950 6.200% | 3,825,950![]() (New Position) | Filing History |

